Guizhou Xinbang Pharmaceutical
Launch date
Employees
Market cap
€719m
Enterprise valuation
€733m (Public information from Sep 2024)
Share price
CNY2.98 002390.SZ
Guiyang Guizhou (HQ)
Financials
Estimates*
| CNY | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenues | - | 6.7b | 5.8b | 6.5b | 6.4b | 6.5b | 63.1b |
| % growth | - | - | (12 %) | 11 % | (2 %) | 2 % | - |
| EBITDA | - | 765m | 662m | 799m | 671m | 733m | - |
| % EBITDA margin | - | 11 % | 11 % | 12 % | 11 % | 11 % | - |
| Profit | - | 236m | 174m | 273m | 224m | 287m | - |
| % profit margin | - | 4 % | 3 % | 4 % | 4 % | 4 % | - |
| EV / revenue | - | 1.7x | 2.6x | 2.4x | 1.5x | 1.3x | - |
| EV / EBITDA | - | 14.5x | 22.8x | 19.0x | 14.3x | 11.7x | - |
| R&D budget | - | 36.6m | 10.6m | 1.9m | 1.2m | 4.7m | - |
| R&D % of revenue | - | 1 % | - | - | - | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| Total Funding | - | ||
